Filter Results :

Your search for Lymphoma returned 125 reports

Sort by


Follicular Lymphoma - Pipeline Review, H1 2015

24 Jun 2015  |  Published by:  Global Markets Direct
Summary‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Follicular Lymphoma, complete with comparative analysis at various stages, therapeutics as...

$ 2,000.00

Read More

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

24 Jun 2015  |  Published by:  Global Markets Direct
Summary‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Diffuse Large B-Cell Lymphoma, complete with comparative analysis at v...

$ 2,000.00

Read More

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

27 May 2015  |  Published by:  GlobalData
SummaryThe Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare organization. The organization provides funding to blood cancer research, and offers education and patient services. It provides services, such as fund raising, patient services, health education, policy advocacy and medical research...

$ 250.00

Read More

Burkitt Lymphoma - Pipeline Review, H1 2015

20 May 2015  |  Published by:  Global Markets Direct
Summary‘Burkitt Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Burkitt Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Burkitt Lymphoma, complete with comparative analysis at various stages, therapeutics assessment ...

$ 2,000.00

Read More

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, T-Cell Lymphomas-API Insights, 2015,report provides T-Cell Lymphomas drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Non-Hodgkin Lymphoma-API Insights, 2015,report provides Non-Hodgkin Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by wor...

$ 1,250.00

Read More

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anaplastic Large Cell Lymphoma (ALCL)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anaplastic Large Cell Lymphoma (ALCL). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collabor...

$ 1,250.00

Read More

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Hodgkin Lymphoma-API Insights, 2015,report provides Hodgkin Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Peripheral T-Cell Lymphomas (PTCL)-API Insights, 2015,report provides Peripheral T-Cell Lymphomas (PTCL) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF)...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Peripheral T-Cell Lymphomas (PTCL)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Peripheral T-Cell Lymphomas (PTCL). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations...

$ 1,250.00

Read More

Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Lymphoblastic Lymphoma-API Insights, 2015,report provides Lymphoblastic Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by...

$ 1,250.00

Read More

The 2016-2021 World Outlook for Lymphoma Therapeutics

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for Lymphoma therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count...

$ 995.00

Read More

Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Burkitt Lymphoma-API Insights, 2015,report provides Burkitt Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Cutaneous T-Cell Lymphoma-API Insights, 2015,report provides Cutaneous T-Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF fi...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Cutaneous T-Cell Lymphoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Cutaneous T-Cell Lymphoma. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and...

$ 1,250.00

Read More
Total 125 records.